Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ:INBS)

1.000 -0.030 (-2.88%)
Streaming Delayed Price Updated: 10:07 AM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intelligent Bio Solutions Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch
Intelligent Bio Solutions awaits FDA clearance for its fingerprint drug test, aiming for a 2025 U.S. launch and expanding its presence in the multi-billion market. 
Via Benzinga
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Which stocks are moving after the closing bell on Wednesday?
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales
Intelligent Bio Solutions reports rising sales and profit margins, driven by recurring revenue from cartridge sales and global expansion through key partnerships. 
Via Benzinga
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Cannabis Death
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
From FN Media Group LLC
Via GlobeNewswire
EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites
Quantum Traffic Management adopts INBS' Intelligent Fingerprinting Drug Testing Solution to improve efficiency and safety, with plans to expand in US. 
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market
Intelligent Bio Solutions collaborates with IVY Diagnostics to enhance drug screening adoption in Europe and the Middle East, targeting key regions. 
Via Benzinga
Harry Simeonidis, CEO of Intelligent Bio Solutions Inc. (NASDAQ: INBS), to Present at NobleCon20
Via Investor Brand Network
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach
NEW YORK - (NewMediaWire) - November 1, 2024 - Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing... 
Via TheNewswire.com
Stocks Driving Market Momentum with Groundbreaking Contracts and Technologies: LUNR, PRSO, LPTH, INBS, PNPN.V
Via AB Newswire
Topics Economy Emissions Energy
Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
 
Via Benzinga
“Intelligent Bio (NASDAQ: INBS), SINTX Technologies (NASDAQ: SINT) Lead Market Surge, and Piedmont, Kaival, Peraso Show Strong Potential”
Via AB Newswire
Topics Intellectual Property
“Stocks to Watch Showing Strong Market Potential INBS, NANO.T, MLGO, KAVL, PNPN.V”
Via AB Newswire
Topics Artificial Intelligence
Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
 
Via Benzinga
What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?
Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The company, specializing in non-invasive testing, advances clinical trials and... 
Via Benzinga
US Stocks Higher; Dow Surges Over 200 Points
 
Via Benzinga
Topics Stocks
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Growth Stocks Across Multiple Sectors-Innovators in Action: MODD, INBS, RCAT, KAVL, WHLR”
Via AB Newswire
Fit to Work: Intelligent Bio Solutions’ (NASDAQ: INBS) Vision for a Healthier, Safer Workplace WISA, BFLY, CLOV, PRSO
Via AB Newswire
A New Standard in Drug Testing: Intelligent Bio (NASDAQ: INBS) Delivering Cost-Efficiency, Rapid Results, and Employee Dignity more stocks inside…
Via AB Newswire
“Must-Watch Stocks: News, Surging Trends in Tech, Biomed, Healthcare, Metals & Energy GDC, INBS, FFIE, PRSO, RJDG”
Via AB Newswire
Topics Artificial Intelligence
Revolutionizing Workplace Safety and Accountability: Intelligent Bio (NASDAQ: INBS) Surpasses 1,000 Installations of Drug Screening Readers, Marking 65% Growth in One Year SMFL, WENA, WW
Via AB Newswire
“Game-Changing Biotech Companies Making Waves: INBS, PMVP, TPST, OMGA, MRSN”
Via AB Newswire
“Explosive Growth Stocks: Innovations, Strategy, Earners Unlock Prime Potential CXAI, OGEN, PRSO, INBS, KAVL”
Via AB Newswire
Topics Artificial Intelligence
Emerging Giants: AI-Driven Innovators Under $2 Set to Transform Markets INBS, PRSO, LPSN, PACB, NINE
Via AB Newswire
Topics Artificial Intelligence
Intelligent Bio Solutions Inc. (Nasdaq: INBS) Announces Major Steps Towards FDA Clearance and U.S. Launch.
Via AB Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.